NCT03724890 2025-04-10
Study of Avelumab-M3814 Combinations
EMD Serono
Phase 1 Completed
EMD Serono
University of Erlangen-Nürnberg Medical School
Abramson Cancer Center at Penn Medicine
Ottawa Hospital Research Institute
OHSU Knight Cancer Institute
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Icahn School of Medicine at Mount Sinai
European Organisation for Research and Treatment of Cancer - EORTC
University of Pittsburgh
Peter MacCallum Cancer Centre, Australia
Radiation Therapy Oncology Group
University of Utah